598P A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC)

Autor: Zhao, J.L., Antonarakis, E.S., Cheng, H., George, D.J., Aggarwal, R.R., Abida, W., Decker, B., Smart-Curley, T., Schonhoft, J., Anderson, A., Haywood, S., Riedel, E., Carver, B., Wyatt, A., Feng, F., Knudsen, K., Rathkopf, D.E.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S643-S644
Databáze: ScienceDirect